These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30140149)

  • 1. Altered community compositions of
    Guan WJ; Yuan JJ; Li HM; Gao YH; Chen CL; Huang Y; Chen RC; Zhong NS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2173-2182. PubMed ID: 30140149
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Guan WJ; Yuan JJ; Li HM; Gao YH; Huang Y; Chen CL; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1095-1105. PubMed ID: 30092878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By
    Huang Y; Chen CL; Yuan JJ; Li HM; Han XR; Chen RC; Guan WJ; Zhong NS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2563-2573. PubMed ID: 31819394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Jiang M; Zheng JP; Chen RC; Zhong NS
    Respir Care; 2015 Aug; 60(8):1180-9. PubMed ID: 26060319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
    Suarez-Cuartin G; Smith A; Abo-Leyah H; Rodrigo-Troyano A; Perea L; Vidal S; Plaza V; Fardon TC; Sibila O; Chalmers JD
    Respir Med; 2017 Jul; 128():1-6. PubMed ID: 28610665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
    Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2015 May; 19(5):610-9. PubMed ID: 25868032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.
    Sibila O; Suarez-Cuartin G; Rodrigo-Troyano A; Fardon TC; Finch S; Mateus EF; Garcia-Bellmunt L; Castillo D; Vidal S; Sanchez-Reus F; Restrepo MI; Chalmers JD
    Respirology; 2015 Oct; 20(7):1082-8. PubMed ID: 26172851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.
    Masekela R; Vosloo S; Venter SN; de Beer WZ; Green RJ
    BMC Pulm Med; 2018 May; 18(1):87. PubMed ID: 29788934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiologic follow-up study in adult bronchiectasis.
    King PT; Holdsworth SR; Freezer NJ; Villanueva E; Holmes PW
    Respir Med; 2007 Aug; 101(8):1633-8. PubMed ID: 17467966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Identification of Bacterial Species Associated with Bronchiectasis via Metagenomic Approach.
    Yang DH; Zhang YY; DU PC; Xu L; Wang HY; Han N; Chen C; Gao ZC
    Biomed Environ Sci; 2014 Nov; 27(11):898-901. PubMed ID: 25374023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Suarez-Cuartin G; Giner J; Merino JL; Rodrigo-Troyano A; Feliu A; Perea L; Sanchez-Reus F; Castillo D; Plaza V; Chalmers JD; Sibila O
    Respir Med; 2018 Mar; 136():111-117. PubMed ID: 29501241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-resistant
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.